Evidence map›Paper›PMID 27670405›Full record

ArticlePhysiological reports2016

Unexpected effects of the MIP-CreER transgene and tamoxifen on β-cell growth in C57Bl6/J male mice.

Bethany A Carboneau, Thao D V Le, Jennifer C Dunn, Maureen Gannon

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Nr4a1 β-cell specific deletion impairs glucose tolerance in female mice.American journal of physiology. Endocrinology and metabolism · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bethany A CarboneauDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee Program in Developmental Biology, Vanderbilt University, Nashville, Tennessee.
Thao D V LeDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee.
Jennifer C DunnDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Maureen GannonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee Program in Developmental Biology, Vanderbilt University, Nashville, Tennessee Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee Department of Veterans Affairs, Tennessee Valley Health Authority, Nashville, Tennessee Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee maureen.gannon@vanderbilt.edu.
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

Training Program in Stem Cell and Regenerative Developmental BiologyT32HD007502 · NICHD · VANDERBILT UNIVERSITY · PI WRIGHT, CHRISTOPHER V · 1997 to 2022
$5.4M
Regulation of adult pancreatic beta cell replicationI01BX000990 · VA · VETERANS HEALTH ADMINISTRATION · PI GANNON, MAUREEN A · 2011 to 2014
–
BLRD VA I01 BX000990BLRD VA I01 BX003744NICHD NIH HHS T32 HD007502
6 · The paper itself

Abstract

Transgenic mouse models have been fundamental in the discovery of factors that regulate β-cell development, mass, and function. Several groups have recently shown that some of these models display previously uncharacterized phenotypes due to the transgenic system itself. These include impaired islet function and increased β-cell mass due to the presence of a human growth hormone (hGH) minigene as well as impaired β-cell proliferation in response to tamoxifen (TM) administration. We aimed to determine how these systems impact β-cell mass and proliferation during high fat diet (HFD). To this end, we utilized C57Bl6/J male MIP-Cre

Indexed as

Human growth hormonetamoxifenβ‐cell massβ‐cell proliferation

Identifiers

PMID27670405
PMCPMC5037909
OpenAlexW2525467030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.